VANTAGE CONSULTING GROUP INC – FibroGen, Inc. Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$7.88M
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
+23.20%
quarter
FibroGen, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.48M | $13.01 | 605.71K | |
| Q2 2022 | share | Increase | +0.09% | 540 shares | -884K | $10.56 | 605.71K |
| Q1 2022 | share | Decrease | -0.09% | -540 shares | -1.26M | $12.02 | 605.17K |
| Q4 2021 | share | 0.00% | 0 shares | 2.35M | $14.12 | 605.71K | |
| Q3 2021 | share | 0.00% | 0 shares | -9.94M | $10.22 | 605.71K | |
| Q2 2021 | share | 0.00% | 0 shares | -4.89M | $26.63 | 605.71K | |
| Q1 2021 | share | 0.00% | 0 shares | -1.44M | $34.71 | 605.71K | |
| Q4 2020 | share | Increase | 0.00% | 605.71K shares | 22.46M | $37.09 | 605.71K |